Tag Archives: Institute of Cancer Research Develops First Foundational Framework for Patient-Reported Outcomes in Early Oncology Trials

Institute of Cancer Research Leads International Effort to Define Use of Patient-Reported Outcomes in Early-Stage Cancer Trials

(IN BRIEF) The Institute of Cancer Research, London, has led the development of OPTIMISE-ROR, the first structured guidance outlining how patient-reported outcomes should be used in early-stage cancer dose-finding trials. Published in the Journal of Clinical Oncology, the recommendations provide … Read the full press release